
MCKESSON CORP
MCKNYSE🏆 #131 by market capEarnings Nov 3US Equity
$901.77▲ $22.45 (+2.49%)
Live1h—
24h▲ 2.5%
7d—
14d—
30d—
1y—
🏦Market Cap
$105.58B
Mid Cap
📈Revenue Growth (YoY)
+8.8%
Slowing
📊Gross Margin
3.6%
Thin
💵FCF Margin
1.6%
Thin
⚖️P/S Ratio
0.3x
Cheap
Otter Score
51
Weak
📊
Analyst Ratings
Price
$901.77
Total
31
Raised
3
Lowered
1
Avg PT
$974.00
| Institution | Action | Rating | Date |
|---|---|---|---|
Citigroup | Reiterated | Buy | 2026-07-24 |
TD Cowen | Reiterated | Buy | 2026-07-21 |
Barclays | Reiterated | Overweight | 2026-06-10 |
Wells Fargo | Reiterated | Equal Weight | 2026-05-12 |
UBS | Reiterated | Buy | 2026-05-08 |
JP Morgan | Reiterated | Overweight | 2026-05-08 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-08 |
B of A Securities | Reiterated | Buy | 2026-04-06 |
Mizuho | Reiterated | Neutral | 2026-02-05 |
Morgan Stanley | Reiterated | Overweight | 2025-11-06 |
Baird | Reiterated | Outperform | 2025-11-06 |
Jefferies | Reiterated | Buy | 2025-10-14 |
Leerink Partners | Reiterated | Outperform | 2025-09-24 |
Deutsche Bank | Reiterated | Buy | 2025-09-24 |
Argus Research | Reiterated | Buy | 2024-06-24 |
Credit Suisse | Reiterated | Outperform | 2023-08-11 |
Cowen & Co. | Reiterated | Outperform | 2022-04-18 |
Goldman Sachs | Reiterated | Buy | 2021-05-07 |
Guggenheim | Reiterated | Buy | 2020-05-27 |
CFRA | Reiterated | Buy | 2020-05-20 |
Standpoint Research | Upgraded | Hold → Buy | 2018-07-10 |
Leerink Swann | Reiterated | Market Perform | 2018-05-29 |
Bank of America | Reiterated | Buy | 2018-04-11 |
RBC Capital | Reiterated | Sector Perform → Perform | 2017-09-19 |
Needham | Reiterated | Hold | 2017-04-04 |
Avondale Partners | Upgraded | Market Perform → Market Outperform | 2017-01-18 |
Raymond James | Reiterated | Market Perform → Perform | 2016-01-12 |
S&P Capital IQ | Downgraded | Strong Buy → Buy | 2014-01-13 |
FBR Capital | Reiterated | Outperform | 2013-10-29 |
ISI Group | Upgraded | Buy → Strong Buy | 2013-10-24 |
Sterne Agee | Reiterated | Buy | 2013-09-18 |
One row per institution, most recent rating